174 related articles for article (PubMed ID: 5067199)
1. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
Coppi G; Bonardi G; Perego R
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
[No Abstract] [Full Text] [Related]
2. Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases.
Fumagalli G; Mazzola C; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:274-8. PubMed ID: 5067204
[No Abstract] [Full Text] [Related]
3. Clinical pharmacology of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
Buniva G; Cattò G; Chierichetti S; Granata D; Manieri G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:258-6. PubMed ID: 4553233
[No Abstract] [Full Text] [Related]
4. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
[No Abstract] [Full Text] [Related]
5. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Anti-inflammatory, analgesic and antipyretic properties.
Bianchi C; Lumachi B; Marazzi-Uberti E
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:183+. PubMed ID: 5067190
[No Abstract] [Full Text] [Related]
6. Survey of the biological properties of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370), a novel agent in the class of anti-inflammatory drugs.
Bianchi C
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:249-5. PubMed ID: 5067202
[No Abstract] [Full Text] [Related]
7. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. Enzyme induction and interaction with other drugs in the rat.
Coppi G; Vidi A; Vanoni PC; Perego R
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:242-6. PubMed ID: 4111897
[No Abstract] [Full Text] [Related]
8. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Subacute and chronic toxicity in rats and dogs.
Gaetani M; Debeus R; Bonardi G; Coppi G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:216+. PubMed ID: 5067196
[No Abstract] [Full Text] [Related]
9. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Study of teratogenic activity in rabbits and rats.
Gaetani M; Debeus R
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:223-6. PubMed ID: 5067197
[No Abstract] [Full Text] [Related]
10. Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
Ghiringhelli F; Mazzi C; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:268-7. PubMed ID: 5067203
[No Abstract] [Full Text] [Related]
11. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 5. Activity on acute experimental synovitis in dogs.
Lumachi B
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:202-4. PubMed ID: 5067193
[No Abstract] [Full Text] [Related]
12. Clinical and pharmacokinetic studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in obstetrics and gynaecology.
Pecorari D; Ragni N; Chierichetti S
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:278-8. PubMed ID: 5067205
[No Abstract] [Full Text] [Related]
13. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 4. Effects on erythrocyte membrane lysis and on red cells aggregation.
Coppi G; Bonardi G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:247-9. PubMed ID: 5067201
[No Abstract] [Full Text] [Related]
14. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. A comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indometacin and benzydamine) in the rat.
Gaetani M; Debeus R; Vidi A; Coppi G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:226-3. PubMed ID: 5067198
[No Abstract] [Full Text] [Related]
15. Absorption and distribution of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA2370) in the rat.
Coppi G; Vidi A; Gallazzi A; Perego R
Arzneimittelforschung; 1974 May; 24(5):801-2. PubMed ID: 4408147
[No Abstract] [Full Text] [Related]
16. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Action on local and systemic chemical responses in the rat with an experimental inflammatory process.
Coppi G; Bonardi G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:237+. PubMed ID: 5067200
[No Abstract] [Full Text] [Related]
17. Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.
Lignière GC; Colombo B; Carrabba M; Ferrari P; Robotti E
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:253-8. PubMed ID: 4553232
[No Abstract] [Full Text] [Related]
18. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 7. Pharmacological comparison with standard anti-inflammatory drugs.
Marazzi-Uberti E; Lumachi B; Gaetani M; Coppi G; Bianchi C
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:213-6. PubMed ID: 5067195
[No Abstract] [Full Text] [Related]
19. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
Bianchi C; Bonardi G
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:196+. PubMed ID: 5067191
[No Abstract] [Full Text] [Related]
20. Physico-chemical and analytical studies on 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
Perego R; Gallazzi A; Vanoni PC; Lucarella I
Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:177+. PubMed ID: 5067189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
